-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
National Health Investors Analyst Ratings
National Health Investors Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 7.54% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 5.8% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -11.54% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 17.94% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 24.88% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 23.15% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 33.55% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | -4.6% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 9.27% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 11.01% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 14.47% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | -4.6% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -30.62% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 5.8% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -25.42% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -11.54% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 42.23% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 64.77% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
08/08/2018 | 38.76% | Cantor Fitzgerald | $75 → $80 | Maintains | Neutral |
05/31/2018 | 30.08% | Wells Fargo | $68 → $75 | Maintains | Market Perform |
04/17/2018 | 4.07% | Keybanc | $70 → $60 | Maintains | Underweight |
12/19/2017 | — | Keybanc | Downgrades | Sector Weight → Underweight | |
10/23/2017 | — | Capital One | Initiates Coverage On | → Equal-Weight | |
10/11/2017 | 38.76% | SunTrust Robinson Humphrey | → $80 | Initiates Coverage On | → Hold |
National Health Investors Questions & Answers
The latest price target for National Health Investors (NYSE: NHI) was reported by Truist Securities on September 26, 2022. The analyst firm set a price target for $61.00 expecting NHI to rise to within 12 months (a possible 5.80% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Truist Securities, and National Health Investors maintained their hold rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on September 26, 2022 so you should expect the next rating to be made available sometime around September 26, 2023.
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $64.00 to $61.00. The current price National Health Investors (NHI) is trading at is $57.66, which is out of the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 7.54% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 5.8% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -11.54% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 17.94% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 24.88% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 23.15% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 33.55% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | -4.6% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 9.27% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 11.01% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 14.47% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | -4.6% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -30.62% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 5.8% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -25.42% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -11.54% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 42.23% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 64.77% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
08/08/2018 | 38.76% | Cantor Fitzgerald | $75 → $80 | Maintains | Neutral |
05/31/2018 | 30.08% | Wells Fargo | $68 → $75 | Maintains | Market Perform |
04/17/2018 | 4.07% | Keybanc | $70 → $60 | Maintains | Underweight |
12/19/2017 | — | Keybanc | Downgrades | Sector Weight → Underweight | |
10/23/2017 | — | Capital One | Initiates Coverage On | → Equal-Weight | |
10/11/2017 | 38.76% | SunTrust Robinson Humphrey | → $80 | Initiates Coverage On | → Hold |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist 证券 | 64 美元 → 61 美元 | 维护 | 保持 |
2022 年 6 月 21 日 | 7.54% | BMO Capital | → 62 美元 | 降级 | 跑赢大盘 → 市场表现 |
04/19/2022 | 5.8% | BMO Capital | 63 美元 → 61 美元 | 维护 | 跑赢大盘 |
2022 年 1 月 2 日 | -11.54% | 瑞士信贷 | → 51 美元 | 启动覆盖范围开启 | → 表现不佳 |
2022 年 7 月 1 日 | 17.94% | BMO Capital | → 68 美元 | 升级 | 市场表现 → 跑赢大盘 |
2021 年 7 月 23 日 | 24.88% | 富国银行 | 74 美元 → 72 美元 | 维护 | 重量相等 |
06/18/2021 | 23.15% | BMO Capital | → 71 美元 | 升级 | 表现不佳 → 市场表现 |
03/30/2021 | 33.55% | 第一资本 | → 77 美元 | 降级 | 超重 → 重量相等 |
2021 年 1 月 13 日 | -4.6% | 瑞穗市 | → 55 美元 | 降级 | 中性 → 跑赢大盘 |
01/08/2021 | — | BMO Capital | 降级 | 市场表现 → 表现不佳 | |
2020 年 12 月 14 日 | — | Keybanc | 升级 | 减持 → 行业权重 | |
2020 年 2 月 9 日 | 9.27% | Stifel | → 63 美元 | 恢复 | → 按住 |
06/24/2020 | 11.01% | SunTrust 罗宾逊·汉弗莱 | 61 美元 → 64 美元 | 维护 | 保持 |
2020 年 6 月 17 日 | 14.47% | 富国银行 | 54 美元 → 66 美元 | 维护 | 重量相等 |
06/08/2020 | — | JMP 证券 | 恢复 | → 市场表现 | |
05/22/2020 | -4.6% | 瑞穗市 | 60 美元 → 55 美元 | 降级 | 买入 → 中性 |
05/14/2020 | -30.62% | Keybanc | 43 美元 → 40 美元 | 维护 | 体重不足 |
04/23/2020 | 5.8% | SunTrust 罗宾逊·汉弗莱 | 77 美元 → 61 美元 | 维护 | 保持 |
2020 年 4 月 21 日 | -25.42% | Keybanc | 65 美元 → 43 美元 | 维护 | 体重不足 |
2020 年 3 月 26 日 | -11.54% | 富国银行 | 82 美元 → 51 美元 | 维护 | 重量相等 |
02/05/2020 | — | 贝伦贝格 | 启动覆盖范围开启 | → 购买 | |
01/07/2020 | 42.23% | BMO Capital | → 82 美元 | 升级 | 表现不佳 → 市场表现 |
12/20/2019 | 64.77% | 瑞穗市 | → 95 美元 | 假设 | → 购买 |
02/20/2019 | — | BMO Capital | 降级 | 市场表现 → 表现不佳 | |
2018 年 8 月 8 日 | 38.76% | 坎托·菲茨杰拉德 | 75 美元 → 80 美元 | 维护 | 中立 |
05/31/2018 | 30.08% | 富国银行 | 68 美元 → 75 美元 | 维护 | 市场表现 |
2018 年 4 月 17 日 | 4.07% | Keybanc | 70 美元 → 60 美元 | 维护 | 体重不足 |
12/19/2017 | — | Keybanc | 降级 | 板块权重 → 减持 | |
10/23/2017 | — | 第一资本 | 启动覆盖范围开启 | → 重量相等 | |
10/11/2017 | 38.76% | SunTrust 罗宾逊·汉弗莱 | → 80 美元 | 启动覆盖范围开启 | → 按住 |
National Health Investors Questions & Answers
全国健康投资者问题与解答
The latest price target for National Health Investors (NYSE: NHI) was reported by Truist Securities on September 26, 2022. The analyst firm set a price target for $61.00 expecting NHI to rise to within 12 months (a possible 5.80% upside). 5 analyst firms have reported ratings in the last year.
Truist Securities于2022年9月26日公布了国家健康投资者(纽约证券交易所代码:NHI)的最新目标股价。该分析公司将目标股价定为61.00美元,预计NHI将在12个月内升至12个月内(可能上涨5.80%)。去年有5家分析公司公布了评级。
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Truist Securities, and National Health Investors maintained their hold rating.
Truist Securities提供了National Health Investors(纽约证券交易所代码:NHI)的最新分析师评级,国民健康投资者维持其持有评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on September 26, 2022 so you should expect the next rating to be made available sometime around September 26, 2023.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与National Health Investors的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。国家健康投资者的最新评级是在2022年9月26日公布的,因此您应该预计下一个评级将在2023年9月26日左右公布。
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $64.00 to $61.00. The current price National Health Investors (NHI) is trading at is $57.66, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的国家健康投资者(NHI)评级维持不变,目标股价为64.00美元至61.00美元。国家健康投资者(NHI)目前的交易价格为57.66美元,超出了分析师的预期区间。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧